A citation-based method for searching scientific literature

Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Marc S Sabatine. Lancet 2019
Times Cited: 518



Karen M Hallow, Gabriel Helmlinger, Peter J Greasley, John J V McMurray, David W Boulton. Diabetes Obes Metab 2018
Times Cited: 90




List of shared articles



Times cited


Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers.
Nienke M A Idzerda, Bergur V Stefansson, Michelle J Pena, David C Sjostrom, David C Wheeler, Hiddo J L Heerspink. Nephrol Dial Transplant 2020
3



Sodium-glucose co-transporter 2 inhibitors and acute heart failure.
Amy Groenewegen, Frans H Rutten. Eur J Heart Fail 2020
0

Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial.
Harpreet S Bajaj, Itamar Raz, Ofri Mosenzon, Sabina A Murphy, Aliza Rozenberg, Ilan Yanuv, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding,[...]. Diabetes Obes Metab 2020
5

Second revolution in cardiovascular prevention.
Chern-En Chiang, Kang-Ling Wang, Hao-Min Cheng, Shih-Hsien Sung, Tze-Fan Chao. J Chin Med Assoc 2020
0

Basic and Clinical Pharmaco-Therapeutics of SGLT2 Inhibitors: A Contemporary Update.
Sanjay Kalra, Kimi K Shetty, Vertivel B Nagarajan, Jignesh K Ved.  2020
3